Press release
Pharmacogenomics Technology (Theranostics & CDx) Market to Set Phenomenal Growth From 2025 to 2034 | Illumina, Roche Diagnostics, Thermo Fisher Scientific
As of 2024, the global pharmacogenomics technology market, encompassing theranostics and companion diagnostics (CDx), is valued at approximately $8.5 billion. This market is poised for significant growth, with a projected valuation of nearly $20 billion by 2034, resulting in a Compound Annual Growth Rate (CAGR) of around 9.1% during the forecast period from 2025 to 2034.Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Pharmacogenomics Technology (Theranostics & CDx) market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Pharmacogenomics Technology (Theranostics & CDx) market.
This report is also available in the following languages : Japanese (薬理ゲノム技術(セラノスティクスおよびCDx)), Korean (약물유전체학 기술(진단 및 CDx)), Chinese (药物基因组学技术(治疗诊断和伴随诊断)), French (Technologie pharmacogénomique (théranostique et CDx)), German (Pharmakogenomik-Technologie (Theranostik & CDx)), and Italian (Tecnologia farmacogenomica (Teranostica e CDx)), etc.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/62358
Key Companies:
Illumina, Inc., Roche Diagnostics, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., Myriad Genetics, Inc., Hologic, Inc., Novartis AG, Aetna Inc., Siemens Healthineers, AstraZeneca PLC, Luminex Corporation, GSK (GlaxoSmithKline), Merck KGaA, Labcorp
Market Segmentation
By Product Type
Test Kits
Software
Services
By Application
Oncology
Infectious Diseases
Cardiovascular Diseases
By End User
Hospitals
Academic Institutions
Research Laboratories
By Technology
NGS
Microarray
PCR
By Distribution Channel
Direct Sales
Online Sales
Explore Full Report here: https://exactitudeconsultancy.com/reports/62358/global-pharmacogenomics-technology-theranostics-cdx-market
If opting for the Global version of Pharmacogenomics Technology (Theranostics & CDx) Market; then the below country analysis would be included:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=62358
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Pharmacogenomics Technology (Theranostics & CDx) market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Pharmacogenomics Technology (Theranostics & CDx) market.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/check-discount/62358
Reasons To Buy The Pharmacogenomics Technology (Theranostics & CDx) Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Our team is available 24/7 to assist and support our customers through reliable research.
Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.
Other Reports:
https://www.openpr.com/news/3900419/variable-data-printing-labels-market-is-set-to-experience
https://www.frenchpolynesiabusinesspress.com/article/729798881-healthcare-it-integration-market-is-expected-to-reach-above-usd-11-42-billion-by-2030-exactitude-consultancy
https://www.mediaindustryobserver.com/article/731261903-vinyl-record-market-is-expected-to-be-valued-at-usd-5-42-billion-by-2033-exactitude-consultancy
https://www.businessjournalflorida.com/article/731583310-multirotor-drones-market-is-expected-to-be-valued-at-usd-10-15-billion-by-2029-exactitude-consultancy
https://banking.einnews.com/pr_news/733380032/toluene-market-is-expected-to-be-valued-at-usd-66-27-billion-by-2033-exactitude-consultancy
https://www.indiamorningtimes.com/article/734285582-battery-materials-market-is-expected-to-be-valued-at-usd-62-12-billion-by-2033-exactitude-consultancy
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Technology (Theranostics & CDx) Market to Set Phenomenal Growth From 2025 to 2034 | Illumina, Roche Diagnostics, Thermo Fisher Scientific here
News-ID: 4085302 • Views: …
More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…

Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…

Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…

ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for CDx
Companion Diagnostics (CDx) Development Market Outlook 2025-2034, Enabling Preci …
As the global healthcare system pivots toward personalized medicine, companion diagnostics (CDx) have emerged as a critical enabler. CDx are in-vitro diagnostic tests designed to identify whether a patient will benefit from a specific drug therapy, ensuring that treatments are safer, more effective, and tailored to individual needs.
These diagnostics are most commonly associated with oncology, where they help match patients to targeted therapies. However, their role is rapidly expanding into…
Global Pharmacogenomics Technology Theranostics CDx Outlook Market Analysis (202 …
LPI (LP Information)' newest research report, the "Pharmacogenomics Technology Theranostics CDx Outlook Industry Forecast" looks at past sales and reviews total world Pharmacogenomics Technology Theranostics CDx Outlook sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmacogenomics Technology Theranostics CDx Outlook sales for 2025 through 2031. With Pharmacogenomics Technology Theranostics CDx Outlook sales broken down by region, market sector and sub-sector, this report provides a…
Pharmacogenomics Technology (Theranostics & CDx) market size ascends with a CAGR …
The global Pharmacogenomics Technology (Theranostics & CDx) market size was valued at USD 9869.6 million in 2022 and is forecast to a readjusted size of USD 24800 million by 2029 with a CAGR of 14.1% during review period. The global Pharmacogenomics Technology market has witnessed remarkable growth in recent years, driven by advancements in genetic research, personalized medicine, and the increasing demand for targeted therapies. Pharmacogenomics, the study of how…
Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Over …
The Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market. On the basis of historic growth analysis and current scenario of Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings…
Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) Marke …
The market study contains demand, application information, price trends, historical and projected market data, company shares of the top Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) providers by region. According on application type, geography, and market size (by volume and value), the report segments the market. This report's main goal is to aid the reader in understanding the market in terms of its definition, segmentation, market potential, significant trends,…
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Pharmacogenomics Technology…